Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Market News
Teva Pharmaceutical Industries Ltd. ADR, TEVA Quick Chart - (NYS) TEVA, Teva Pharmaceutical Industries Ltd. ADR Stock Price - BigCharts.com
Israel stocks tick lower; Teva, Itamar in focus - MarketWatch
Teva Pharmaceutical Industries Ltd. (TEVA) Moves 7.5% Higher: Will This Strength Last?
TEVA — TradingView
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva shares surge on corporate shake-up - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
What Kind Of Shareholders Hold The Majority In Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Shares?
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals - Crunchbase Company Profile & Funding
Israel stocks rise, led by Teva, ICL - MarketWatch
Israel stocks up; FTC eyes Teva-Cephalon deal - MarketWatch
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Mylan tries to fend off Teva with bigger bid for Perrigo - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Opinion: Multinationals learn the limits of being big - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Leaner, More Agile Teva Sees Brighter Days Ahead
Israel stocks steady; Teva settles with Takeda - MarketWatch
Israel stocks fall for fifth day; Teva rises - MarketWatch
TEVA — TradingView
